4.5 Article

A cross-linking approach to map small molecule-RNA binding sites in cells

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 29, 期 12, 页码 1532-1536

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2019.04.001

关键词

RNA; Small molecules; Target validation; Target profiling; Oncogenic microRNA

资金

  1. National Institutes of Health [R01 GM097455]

向作者/读者索取更多资源

Methods to identify RNAs bound by small molecules in cells are sparse. Herein, an advance to identify the direct RNA targets of small molecules in cells is described. The approach, dubbed Chemical Cross-Linking and Isolation by Pull-down to Map Small Molecule-RNA Binding Sites (Chem-CLIP-Map-Seq), appends a cross-linker and a purification tag onto a small molecule. In cells, the compound binds to RNA and undergoes a proximity-based reaction. The cross-linked RNA is purified and then amplified using a universal reverse transcription (RT) primer and gene-specific PCR primers. At nucleotides proximal to the binding site, RT stops are observed. This approach has broad utility in identifying and validating the RNA targets and binding sites of small molecules in the context of a complex cellular system.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Systematically Studying the Effect of Small Molecules Interacting with RNA in Cellular and Preclinical Models

Jessica A. Bush, Christopher C. Williams, Samantha M. Meyer, Yuquan Tong, Hafeez S. Haniff, Jessica L. Childs-Disney, Matthew D. Disney

Summary: The manipulation of biological systems by small molecules is a powerful approach in chemical biology, with a focus on targeting RNA as an attractive therapeutic alternative. The systematic evaluation of target validation and modulation of target-associated pathways is of paramount importance as the field of RNA chemical biology emerges. Through case studies, the impact of small molecules that target RNA on cellular phenotype is comprehensively evaluated in this Review.

ACS CHEMICAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Affecting RNA biology genome-wide by binding small molecules and chemically induced proximity

Jared T. Baisden, Jessica L. Childs-Disney, Lucas S. Ryan, Matthew D. Disney

Summary: The ENCODE and genome-wide association projects have found that most of the genome is transcribed into RNA, with the druggable transcriptome being larger than the druggable proteome. Strategies to target RNA and the unique modes of action suggest that RNAs are potentially more amenable to targeting than proteins.

CURRENT OPINION IN CHEMICAL BIOLOGY (2021)

Article Chemistry, Medicinal

A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways

Sarah Wagner-Griffin, Masahito Abe, Raphael Benhamou, Alicia J. Angelbello, Kamalakannan Vishnu, Jonathan L. Chen, Jessica L. Childs-Disney, Matthew D. Disney

Summary: This study presents druglike small molecules that bind and improve defects associated with DM2 by targeting the RNA repeat expansion. Through optimization of small molecules binding the structure adopted by r(CCGU)(exp), endogenous degradation of the aberrantly retained intron, and rescue of alternative splicing defects are achieved.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Editorial Material Chemistry, Multidisciplinary

A Few Revolutions of the RNA World in ACS Publications

Matthew D. Disney

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Article Biochemistry & Molecular Biology

Bioinformatic Searching for Optimal RNA Targets of Dimeric Compounds Informs Design of a MicroRNA-27a Inhibitor

Raphael Benhamou, Shruti Choudhary, Elizabeth Lekah, Yuquan Tong, Matthew D. Disney

Summary: Studies have shown that selective molecular recognition of RNA targets by small molecules in cells is possible, with one strategy being the simultaneous binding of two or more sites within RNA with a single molecule. By informatically mining human miRNA precursors, targets amenable to small molecule targeting can be identified, with oncogenic miRNA-27a being a lead molecule that can inhibit miRNA processing in cancer cells. This demonstrates that a synergistic approach involving bioinformatics and experimental methods can define suitable targets for small molecule targeting.

ACS CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

A Small Molecule Exploits Hidden Structural Features within the RNA Repeat Expansion That Causes c9ALS/FTD and Rescues Pathological Hallmarks

Andrei Ursu, Jared T. Baisden, Jessica A. Bush, Amirhossein Taghavi, Shruti Choudhary, Yong-Jie Zhang, Tania F. Gendron, Leonard Petrucelli, Ilyas Yildirim, Matthew D. Disney

Summary: A small molecule (CB253) has been discovered to selectively bind the hairpin form of the hexanucleotide repeat expansion RNA in c9ALS/FTD patients, shifting the equilibrium towards a different internal loop conformation and inhibiting pathogenic mechanisms.

ACS CHEMICAL NEUROSCIENCE (2021)

Review Biotechnology & Applied Microbiology

Targeting RNA structures with small molecules

Jessica L. Childs-Disney, Xueyi Yang, Quentin M. R. Gibaut, Yuquan Tong, Robert T. Batey, Matthew D. Disney

Summary: Disney and colleagues review strategies for identifying, validating, and optimizing small-molecule RNA binders, and discuss challenges and future directions in the field.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Chemistry, Multidisciplinary

Low-Molecular Weight Small Molecules Can Potently Bind RNA and Affect Oncogenic Pathways in Cells

Blessy M. Suresh, Yoshihiro Akahori, Amirhossein Taghavi, Gogce Crynen, Quentin M. R. Gibaut, Yue Li, Matthew D. Disney

Summary: By constructing a comprehensive RNA-focused small-molecule fragment collection and studying the binding landscape of different fragments to RNA experimentally, a potent and specific drug-like fragment targeting a specific RNA target was discovered, showing promising application in alleviating oncogenic features of certain cancer cells.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Chemistry, Multidisciplinary

Study of an RNA-Focused DNA-Encoded Library Informs Design of a Degrader of a r(CUG) Repeat Expansion

Quentin M. R. Gibaut, Yoshihiro Akahori, Jessica A. Bush, Amirhossein Taghavi, Toru Tanaka, Haruo Aikawa, Lucas S. Ryan, Brian M. Paegel, Matthew D. Disney

Summary: In this study, a solid-phase DNA-encoded library (DEL) was used to identify and optimize RNA binders for adult-onset muscular dystrophy. One binder was found to specifically bind the causative agent and improved disease-associated defects by attaching it with a module that cleaves the agent.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Chemistry, Medicinal

Fragment-Based Approaches to Identify RNA Binders

Blessy M. Suresh, Amirhossein Taghavi, Jessica L. Childs-Disney, Matthew D. Disney

Summary: Although there are challenges in fragment-based drug discovery (FBDD) for RNA targets, some bioactive ligands have been identified by integrating known methods of RNA binder discovery with fragment-based approaches. This review discusses various fragment-based approaches for RNA targets, providing insights into experimental design and outcomes for future research. Investigations into the molecular recognition of RNA by fragments address important questions such as the limits of molecular weight for selective binding and the physicochemical properties favorable for RNA binding and bioactivity.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Optimization of a Protein-Targeted Medicine into an RNA-Specific Small Molecule

Samantha M. Meyer, Toru Tanaka, Amirhossein Taghavi, Jared T. Baisden, Maison Grefe, Matthew D. Disney

Summary: This study designs molecules that specifically inhibit RNA targets without affecting canonical protein targets, based on knowledge of the molecular recognition of both protein and RNA targets by dovitinib.

ACS CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Altering the Cleaving Effector in Chimeric Molecules that Target RNA Enhances Cellular Selectivity

Blessy M. Suresh, Yuquan Tong, Daniel Abegg, Alexander Adibekian, Jessica L. Childs-Disney, Matthew D. Disney

Summary: This study investigates the factors affecting the degradation of two cancer-associated RNA targets and explores how structural features can be leveraged to program selective small-molecule degradation. The findings have important implications for the development of chemical probes and potential lead medicines targeting RNA.

ACS CHEMICAL BIOLOGY (2023)

Article Chemistry, Multidisciplinary

DNA-Encoded Libraries and Their Application to RNA

Xueyi Yang, Jessica L. Childs-Disney, M. Paegel, Matthew D. Disney

Summary: The functional roles of structured RNAs in biological processes are now being recognized, leading to the potential of RNA as a therapeutic target. Robust and high-throughput methods for identifying potent RNA ligands are crucial for developing chemical probes and therapeutics. The use of DNA-encoded libraries (DEL) technology has emerged as a powerful tool for discovering protein ligands and offers unprecedented opportunities for designing RNA ligands. In this review, we discuss the principles of DEL selection, the progress made in targeting RNA using DEL, and the future outlook.

ISRAEL JOURNAL OF CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG)exp Degrader in Myotonic Dystrophy

Quentin M. R. Gibaut, Jessica A. Bush, Yuquan Tong, Jared T. Baisden, Amirhossein Taghavi, Hailey Olafson, Xiyuan Yao, Jessica L. Childs-Disney, Eric T. Wang, Matthew D. Disney

Summary: This study introduces a pipeline to identify and eliminate the r(CUG) repeat expansion causing DM1 in cells.

ACS CENTRAL SCIENCE (2023)

Editorial Material Clinical Neurology

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit

Rita Sattler, Bryan J. Traynor, Janice Robertson, Ludo Van den Bosch, Sami J. Barmada, Clive N. Svendsen, Matthew D. Disney, Tania F. Gendron, Philip C. Wong, Martin R. Turner, Adam Boxer, Suma Babu, Michael Benatar, Michael Kurnellas, Jonathan D. Rohrer, Christopher J. Donnelly, Lynette M. Bustos, Kendall Van Keuren-Jensen, Penny A. Dacks, Marwan N. Sabbagh

Summary: The summit highlighted the role of the C9ORF72 gene in FTD and ALS, covering disease mechanisms, therapeutic strategies, and biomarkers. Collaborative efforts aimed to break down existing disease silos and proposed composite endpoints for evaluating treatments covering clinical symptoms.

NEUROLOGY AND THERAPY (2023)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)